Brillia Health Cough Control

Manufacturer
Hadaf LLC | Santonika Uab
Effective date
2020-07-31
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 23:19:40

Label at a glance#

ProductBrillia Health Cough Control
Active ingredientLAPINE MORPHINE IMMUNE GLOBULIN, LAPINE BRADYKININ IMMUNE GLOBULIN, LAPINE HISTAMINE IMMUNE GLOBULIN
Label structure13 sections

Indications and uses

• Suppresses wet and dry cough • Reduces severity and duration of symptoms, including nasal congestion, cough and sore/itchy throat • Antihistamine and decongestant/anti-inflammatory • Reduces sore throat pain

Dosage and administration

• For adults and children 3 years and older. • Take orally by holding tablet in the mouth until completely dissolved, without food. • 1 to 2 tablets 3 times daily. For severe symptoms, take 4 to 6 times daily for the first 3 days.

Storage and handling

• Store in original package below 25°C or 77°F. • Do not use if blister pack is torn or broken.

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Lapine bradykinin immune globulin 12C, 30C, 50C Purpose Reduces frequency and intensity of cough
Lapine morphine immune globulin 12C, 30C, 50C Purpose Reduces pain response
Lapine histamine immune globulin 12C, 30C, 50C Purpose.Reduces histamine and inflammation response

Purpose

OTC - PURPOSE SECTION

Homeopathic,
Reduces frequency and intensity of cough
Reduces pain responseLapine histamine immune
Reduces histamine and inflammation response

Uses

INDICATIONS & USAGE SECTION

• Suppresses wet and dry cough
• Reduces severity and duration of symptoms, including nasal congestion, cough and sore/itchy throat
• Antihistamine and decongestant/anti-inflammatory
• Reduces sore throat pain

Warnings

WARNINGS SECTION

Stop use and ask a doctor if symptoms persist or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Allergic (hypersensitivity) reactions may occur in very rare cases.
Do not use if known sensitivity to Brillia Health Cough Control or
any of its ingredients exists.

Stop use

OTC - STOP USE SECTION

Stop use and ask a doctor if symptoms persist or worsen.

Pregnancy

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Allergies

OTHER SAFETY INFORMATION

Allergic (hypersensitivity) reactions may occur in very rare cases.

Do Not Use

OTC - DO NOT USE SECTION

Do not use if known sensitivity to Brillia Health Cough Control or
any of its ingredients exists.

Directions

DOSAGE & ADMINISTRATION SECTION

• For adults and children 3 years and older.
• Take orally by holding tablet in the mouth until completely dissolved, without food.
• 1 to 2 tablets 3 times daily.
For severe symptoms, take 4 to 6 times daily for the first 3 days.

Other Information

STORAGE AND HANDLING SECTION

• Store in original package below 25°C or 77°F.
• Do not use if blister pack is torn or broken.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Isomalt, Microcrystalline cellulose, Magnesium stearate, Citric acid (anhydrous), Aspartame, Sodium saccharin.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

20 Tablets NDC: 72123-005-01

LABEL 1LABEL 1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72123-00572123-005-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d5e1da7d-5568-d48d-e053-2a95a90a2d1cabc7a32d-bea0-c99e-e053-2a95a90a62bf2022-01-18WarningsExact identifier
spl set id: abc7a32d-bea0-c99e-e053-2a95a90a62bf

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.